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Purpose: With clinical progression of chronic venous insufficiency (CVI), dermal 
infiltration of mononuclear cells increases. Because these cells regulate chronic inflam- 
matory responses and modulate wound healing, cellular dysfunction could explain 
alterations in wound healing with CVI. The purpose of this study was to determine 
whether monocytes in patients with CVI are dysfimctional. 
Methods: Mononuclear cell fianction was measured as the degree of proliferation in 
response to a mitogenic hallenge. Fifty patients were separated into four groups: group 
1, 14 patients with normal imbs; group 2, 10 patients with class 2 CVI; group 3, 15 
patients with active venous ulcers; group 4, 11 patients with healed venous ulcers and 
current evidence of lipodermatosclerosis. Duplex scanning and air plethysmography 
correlated with the clinical classification of CVI. Systemically circulating monocytes and 
lymphocytes were obtained by antecubital venipunctnre from groups 1 to 4. Cells were 
cultured in the presence of staphylococcal enterotoxins A, B, C~, D, and E (mitogens) at 
1, 8, 31, and 125 I~g/well on the basis of previous dose-response experiments. 
Phytohemagglutinin (PHA), 5 ~g/well, served as a control mitogen. The dose-response 
curves indicated that 8 ~g/well elicited the greatest degree of cell proliferation. 
Proliferative responses at 8 ~g/well were analyzed for statistical significance among roups 
1 to 4. Comparisons among groups were performed by use of the nonparametric Mann 
Whitney lJ post tests and a one-tailed unpaired t test. Results were considered significant 
atp < 0.05. 
Results: Proliferative responses to PHA indicate that lymphocytes and monocytes from 
patients with CVI are not globally depressed. However, patients in group 2 did not exhibit 
the same degree of proliferation to PHA as did groups 1, 3, and 4. Proliferative responses 
between groups 2 and i (44.38 + 43.9 vs 118.87 + 27.1,p < 0.05) and groups 2 and 3 
(44.38 + 43.9 vs 105.95 + 60.99, p -< 0.05) were significant. Challenges with staphy- 
lococcal enterotoxin A and B reveal significant diminution of proliferative responses in 
groups 2 (42.73 + 11.55, p < 0.05) and 3 (45.57 + 9.1, p < 0.05) and groups 3 
(36.81 + 6.9,p < 0.05) and 4 (35.04 + 7.5, p -< 0.05), compared with staphylococcal 
enterotoxin A controls (68 .68-  9.9) and staphylococcal enterotoxin B controls 
(66.25 --- 13.56), respectively. A trend of diminished mononuclear cell function with 
progression of CVI was observed with staphylococcal enterotoxins B, C1, D, and E, 
strongly suggesting biologic significance. Furthermore, patients with lipodermatosderosis 
uniformly exhibited the poorest proliferative responses. 
Conclusions: Deterioration of mononuclear cell function is associated with CVI. A trend 
of diminishing proliferative responses with clinical disease progression is observed and 
suggests biologic significance. The decreased capacity for mononudear cell proliferation 
in response to various challenges may manifest itself clinically as poor and prolonged 
wound healing. (J VASC SURG 1995;22:580-6.) 
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Chronic venous insufficiency (CVI) is the seventh 
leading cause of chronic debilitating disease in the 
United States.1 Ten to thirty-five percent of adults in 
the United States has some form of venous disorder, 
and more than 500,000 people have venous stasis 
ulcers. 1'2 Numerous theories regarding the cause of 
CVI have focused on the neutrophil as the cell re- 
sponsible for the skin alterations associated with the 
disease. 1 However, recent studies by Smith et al.s 
have indicated that lymphocytes and monocytes are 
involved in the pathophysiology of CVI. What role 
these cells are playing and the consequences of an 
absent epithelial barrier on their function have not 
been investigated in this patient population. The pur- 
pose of this study is to determine whether lympho- 
cytes and monocytes, regulators of inflammation and 
epidermal regeneration, are functionally altered. The 
proliferative response to various mitogenic stimuli as 
measured by the incorporation of tritiated thymidine 
was used as a marker of cellular function. 
MATERIAL AND METHODS 
Fifty patients were prospectively enrolled in the 
study. The study was approved by the institutional 
review board, and informed consent was obtained 
before enrollment. Patients were separated into one 
of four groups. Group 1, control patients, consisted 
of 14 patients with no history of CVI. Group 2 con- 
sisted of 10 patients with International Society of 
Cardiovascular Surgery/Society of Vascular Surgery 
(ISCVS/SVS) class 2 CVI. Group 3 consisted of 15 
patients with active venous ulcers, ISCVS/SVS class 
3 CVI, and group 4 consisted of 11 patients with a 
history of numerous venous ulcers and present lipo- 
dermatosclerosis (LDS). To assure that alterations 
observed in lymphocyte and monocyte function were 
due to CVI alone and not to immunoreactive or
immunosuppressive conditions, the following condi- 
tions were considered exclusionary: active infection, 
cancer, surgery within 6 weeks, rheumatoid arthritis, 
vasculitis, collagen vascular disease, history of intra- 
venous drug abuse, or use of steroid medications. 
Hemodynamic assessment 
Patients in Groups 2 to 4 underwent air plethys- 
mography (APG) and venous duplex analysis to con- 
firm the presence of CVI. The site of valvular incom- 
petence, the pattern of reflux, and the location of 
chronic venous obstruction in deep and superficial 
systems were determined with duplex scanning used 
in a manner previously described by Araki et al. 4 All 
duplex scanning measurements were performed with 
a 5 MHz imaging/5 MHz pulsed-wave Doppler 
color-flow system (Quantum 2000; Siemens Inc., 
Seattle, Wash.). An APG-1000 Air Plethysmograph 
(ACI Medical, Sun Valley, Cafif.) was used to per- 
form the APG analysis. Most patients had bilateral 
lower extremity venous disease. Inclusion into a clini- 
cal group was based on the more diseased extremity. 
Proliferation techniques and 
dose-response experiment 
To determine the concentrations and staphylo- 
coccal enterotoxins (SEs) that caused optimal pro- 
liferative responses, a dose-response experiment was 
performed on four patients without venous insuf- 
ficiency. Thirty milliliters of whole blood was col- 
lected via an antecubital rm vein venipuncture, in
citrate/phosphate/dextrose tub s. Ten-milliliter ali- 
quots of whole blood were layered over 4 ml 
Ficoll-Hypaque (Sigma Chemical Co., St. Louis, 
Mo.) and centrifuged at 1500 rpm for 25 minutes. 
After centrifugation, the huffy coat was transferred 
to a sterile 15 ml tube, and the cells were washed 
once with complete Hanks balanced salt solution. 
After being washed, the cells were resuspended in
RPMI and counted. Once counted the concentra- 
tion was adjusted to 1 x 106 cells/ml. Cells were 
incubated in a 5% CO 2 incubator at 37 ° C for 96 
hours in the presence of RPMI 1640 (Roswell Park 
Memorial Institute, JRI Biosciences, Kansas City, 
Mo.), L-glutamine, 20% human albumin serum, 
penicillin, and streptomycin antibiotic. Cells were 
placed in 96-well microtiter plates and cultured in 
the presence of a serial dilution of SEs A, B, C1, 
D, and E. All cell culturing was performed with use 
of a sterile technique in laminar flow hoods and in 
triplicate at each SE concentration. Three wells with 
cells alone and three wells with cells and phyto- 
hemagglutinin (PHA) acted as internal controls. At 
day 4 each well was pulsed with 1 p.Ci tritiated 
thymidine. After 6 hours of incubation, the cells 
were harvested, and the degree of thymidine uptake 
was measured with a beta scintillation counter. The 
degree of thymidine uptake was recorded as a 
stimulation index. The stimulation index was de- 
rived by dividing the mean of the counts per minute 
of cells cultured with enterotoxin by the mean of 
the counts per minute of the cells cultured without 
enterotoxin. A dose-response curve was then gen- 
erated by plotting stimulation indexes against in- 
creasing SE concentrations. From these initial ex- 
periments it was determined that 8 ~g/well induced 
maximal stimulation in patients without CVI. 
Time course experiment 
The incubation period used for the above experi- 
ments was based on similar time course experiments 
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Fig. 1. Histogram of leukocyte proliferative r sponses on exposure to PHA and SE A, B, C1, 
D, and E. Asterisk represents p -< 0.05 compared with controls; double asterisk represents 
p -< 0.05 PHA group 2 compared with PHA group 3. 
performed in our laboratory. However, to determine 
the optimal incubation period for incorporation of 
tritiated thymidine in this patient population, a time 
course experiment was performed. Cells were incu- 
bated in the presence and absence of enterotoxins for 
3 and 4 days. These experiments demonstrated that 
the optimal incubation period for tritiated thymidine 
incorporation was 3 and 4 days. 
Study group proliferation experiments 
Thirty milliliters of blood were then obtained 
from patients in groups 1 to 4. Lymphocytes and 
monocytes were isolated and cultured as described 
above. Cells were cultured in triplicate in the presence 
of SEs A, B, C1, D, and E at 1, 8, 31, and 125 
~g/well. Three wells of cells alone and three wells of 
cells cultured in the presence of PHA acted as internal 
controls. Cells were cultured for 96 hours, pulsed 
with tritiated thymidine, and harvested 6 hours later. 
The degree of thymidine incorporation was mea- 
sured as with a beta scintillation cotmter, and stimu- 
lation indexes were determined. Stimulation indexes 
were plotted against he above-determined SE con- 
centrations, and PHA and dose-response curves were 
obtained. 
Statistical methods 
Data, including stimulation indexes, are pre- 
sented as mean plus or minus standard error of the 
mean. Differences were assessed for statistical signifi- 
cance (p _< 0.05) by use of the nonparametric 
Mann-Whitney U test and a one-tailed unpaired t test. 
The statistical software package Graphpad Instat 
(Graphpad Software, Inc., San Diego, Calif.) was 
used. 
RESULTS 
Patient demographics 
Patients in group 1, controls, consisted of 14 male 
patients, age 61.9 + 7.7 years, with no history of 
venous insufficiency. Group 2 consisted of 10 pa- 
tients, age 65 + 13.4 years, with ISCVS/SVS class 2 
venous insufficiency. Group 3 consisted of 15 pa- 
tients, age 67.9 ___ 9.6 years, with active venous 
ulcers. Group 4 consisted of 11 patients, age 
64.8 _+ 9.3 years, with a history of venous ulceration 
who had development ofLDS. Differences in patient 
age between groups were not significant. The average 
duration of venous insufficiency was 17.26 ___ 3.75 
years and 47 of the 50 patients in the study were men. 
The average duration of an active venous ulcer before 
enrollment into the study was 4.71 _+ 1.34 months. 
Noninvasive hemodynamic assessment 
To confirm the presence ofCVI, APG and venous 
duplex scanning were performed on all but three 
patients. One patient with class 2 CVI and two 
patients with active venous ulcers were lost to 
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Table I. APG data 
OF VII EF R VF 
Group 2 65.4 -+ 10.1 ~3.5 + 2.1 248.8 + 10 252 + 14.6 
Group 3 51.8 + 10.3 ~6.6 +_ 4.1 ~44.8 _+ 20.5 ~65 -+ 21 
Group 4 48.5 -+ 17.0 ¢6.5 -- 3.4 ~46.9 _+ 16.9 245.6 + 18.3 
2 = Abnormal Value. Outflow Fraction (OF > 38%), Venous Filling Index (VFI < 1.8 sec), Ejection Fraction (EF > 60%), Residual 
Volume Fraction (RVF < 35%). 
OF, Outflow fraction; VFI, venous filling index; EF, ejection fraction; RVF, residual volume fraction. 
~Abnormal value. OF > 38%; VFI < 1.8 seconds; EF > 60%; RVF < 35%. 
Table II. Site of valvular incompetence by 
duplex scanning 
follow-up. Results of APG and duplex scanning 
assessment are presented in Tables I and II. All 
patients, except two in group 4, exhibited evidence of Deep system Superficial system Both None 
valvular incompetence by duplex scanning. The two 
patients in group 4 with a normal duplex assessment Group 2 0 1 5 1 
Group 3 2 3 6 0 
had numerous venous stasis ulcers in the past and Group 4 1 0 8 2 
clinical evidence of LDS. 
Cell proliferation assessment 
All mononuclear cell cultures were performed 
in triplicate and with two internal controls. Cells 
cultured in the absence of SEs assured that no 
unknown stimulants or inhibitors were present in the 
culuare plates. The general responsiveness of cells to 
mitogenic stimuli was tested by culturing aset of cells 
in the presence of PHA. Cells from patients in groups 
1 to 4 uniformly responded to PHA, indicating that 
the cells were not globally immunosuppressed (Fig. 
1). Even though the cells were uniformly responsive, 
cells from group2 (44.38 + 43.9,p _< 0.05)didnot 
exhibit the same degree of proliferation to PHA 
stimulation as did groups 1 (118 +_ 37.2), 3 
(105.9 _+ 60 > 9), and 4 (108.9 _+ 19.5). Com- 
pared with controls (group 1) and patients with 
active ulcers (group 3), the differences were sig- 
nificant at 8 ~g/well after a 96-hour incubation 
period. 
Fig. 2 presents the dose-response data for SE B. 
Similar dose-response curves were obtained for SE A, 
C1, D, and E. The maximum degree of tritiated 
thymidine incorporation was elicited by the dose of 
8 ~g/well. 
In response to SE A, proliferative responses of 
group 2 (42.73 _+ 11.55,p < 0.05) and 3 (45.57 _+ 
9.1, p _< 0.05), compared with SE A controls 
(68.68 + 9.9), were significantly decreased (Fig. 3). 
Similarly, in response to SE B, proliferative r sponses 
of group 3 (36.81_+6.9, p_<0.05) and 4 
(35.04 + 7.5,p < 0.05), compared with SE B con- 
trois (66.25 + 13.56, p _ 0.05), were significantly 
decreased (Fig. 4). Furthermore, responses to chal- 
lenges with SE C, SE D, and SE E approached 
significance. For SE C, stimulation indexes of group 
4 were 33.93 + 6.8 versus 55.61 + 9.9 for controls 
(p -< 0.06). For SE D, stimulation indexes were 
31.6 _+ 6.5, p _< 0.0509 for group 3 and 28.8 _+ 
6.6, p _< 0.06 for group 4 versus 42.45 + 6 for 
controls. For SE E, stimulation indexes were 
40.71 + 8.2,p _< 0.0509 for group 3 and 41.19 + 
8.45, p < 0.07 versus 56.58 + 8.09 for controls. 
Differences in proliferative r sponses between groups 
2, 3, and 4 were not significant regardless of the 
enterotoxin used. However, a consistent trend of 
diminishing responsiveness with clinical disease pro- 
gression is observed with each enterotoxin used 
except for SEA (Fig. 1). Furthermore, patients with 
LDS, group 4, almost uniformly exhibited the 
poorest responses after mitogenic hallenges. This 
consistent rend of diminishing mononuclear cell 
function, regardless of the enterotoxin used, strongly 
suggests biologic significance. 
DISCUSSION 
Although the association between venous hyper- 
tension and CVI is well known, the pathophysiologic 
condition leading to skin discoloration, eventual 
ulcer formation, and prolonged wound healing 
remains ill defined. 1 Numerous theories regarding 
the cause of CVI have been proposed; however, the 
mechanisms underlying the prolonged wound heal- 
ing associated with CVI and the consequences of an 
absent epithelial barrier on cellular function have not 
been investigated in this patient population? ,5 
The link between venous hypertension and cel- 
lular responses ties in the effect that increased 
hydrostatic pressure has on post-capillary venules. 
Venous hypertension causes widening of the en- 
dothelial gap junctions, resulting in interstitial de- 
position of fibrinogen. 68 Burnand et al.8 postulated 
JOURNAL OF VASCULAR SURGERY 
584 Pappas et al. November 1995 
75- 
)< 
0 
"0 
-= 50- 
C 
o 
,,,1 
.E 25- 
I I I I 
1 8 31 125 
microgram/wel l  
- -~  CONTROLS 
CV! II 
--c-- ACTIVE ULCERS 
--o-- LDS 
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Fig. 3. Histogram of statistical analysis of cellular proliferation (stimulation index) after 
challenge with SE A as function of progressive stages of venous disease. There is diminution in 
cellular proliferation between groups 2 and 3 compared with controls. Asterisk represents 
p _< 0.05. 
that the extracellular deposition of fibrinogen was 
responsible for the pericapillary cuff observed sur- 
rounding post-capillary venules of patients with 
CVI. However, these cuffs are more complex than 
originally reported. They are composed of laminin, 
fibronectin, tenascin, and collagen types I and III. 9 
These compounds are extracellular matrix proteins 
(ECM) commonly found in ground substance. 
These proteins are also potent chemoattractants, a  
well as leukocyte and platelet activators, when 
exposed to circulating components of blood. Ex- 
posure of these ECM proteins, as a result of venous 
hypertension, may be the underlying stimulus re- 
sponsible for the chronic inflammatory response 
observed in the skin of patients with CVI. 
The cells responsible for cuff formation are 
unknown. Endothelial cells and fibroblasts are both 
capable of producing the above ECM proteins. Cuff 
production by endothelial cells of post-capillary 
venules may be an attempt to bridge the widening in 
gap junctions produced by venous hypertension. 
Subsequent exposure of ECM proteins to cellular 
elements of circulating blood may lead to activation. 
Venous hypertension also causes extravasation f red 
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Fig. 4. Histogram of statistical analysis of cellular proliferation (stimulation index) after 
challenge with SE B as function of progressive stages of venous disease. There is diminution in 
cellular proliferation between groups 3 and 4 compared with controls. Asterisk reresents 
p <- 0.05. 
blood cells into the interstitium of the post-capillary 
venule. These red blood cells die and serve as an 
additional stimulus for leukocyte and platelet activa- 
tion. Whatever the cause, platelet and leukocyte 
activation leads to cytokine production with subse- 
quent regulatory effects on the inflammatory process 
and epidermal regeneration. 
Numerous cytokines play a regulatory role in 
tissue repair and epidermal regeneration; however, 
their temporal relationship to each other is not 
l~nown. Transforming rowth factor-a, basic fibro- 
blast growth factor, interferon-y, and tumor necrosis 
factor-a (TNF-a) have all been reported to affect 
keratinocyte and fibroblastic activation and migra- 
tion. Transforming rowth factor-a binds to epider- 
mal growth factor eceptors on the cell membrane of 
keratinocytes and stimulates keratinocyte division 
and migration in vitro, t° Transforming growth 
factor43, interferon--/, and TNF-a cause inhibition of 
epidermal growth in vivo and in vitro 7 and are also 
used to impede bacterial and viral overgrowth. 
Theoretically, an overprotection of inhibitory cyto- 
kines, in an effort to control bacterial and viral 
overgrowth, could impede epidermal regeneration. 
Dermal cytokine level changes of interleukin-la nd 
interleukin-1 ~3 but not of TNF-a have been reported 
by Smith et al.3 in patients with severely liposclerotic 
sldn. Regulation of the ECM protein and cytokine 
production in the venous microenvironment may 
provide areas for future therapeutic ntervention. 
Lymphocyte and monocyte dermal infiltration 
with clinical disease progression of CVI suggests the 
presence of a chronic proinflammatory stimulus in 
the venous microcirculation. The normal response of 
lymphocytes and monocytes to an acute injury is to 
enter the site of injury and proliferate for approxi- 
mately 6 weeks. After 6 weeks the cells begin to 
migrate slowly away from the incision site. By 8 
months no mononuclear cells are present, n In CVI, 
mononuclear cell levels do not appear to diminish 
and progressively increase with clinical deteriora- 
tion. 6 Stimulated by this observation we hypothe- 
sized that lymphocyte and monocyte xposure to the 
venous microcirculation in patients with CVI is 
associated with qualitative differences in fimction. 
Circulating lymphocytes and monocytes from pa- 
tients in groups 1 to 4 were exposed to various 
mitogens potentially present in venous ulcers. Be- 
cause wound cultures obtained from our patients 
with venous stasis ulcers demonstrated that most 
patients had colonies of Staphylococcus aureus, SE 
were used as mitogens, t2 We hypothesized that 
bacterial colonization with concomitant toxin pro- 
duction may cause inhibition of lymphocyte and 
monocyte proliferation. Without proliferation cyto- 
kine elaboration cannot occur. 
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Our data indicate that CVI is associated with a 
diminished capacity for cellular proliferation. A 
consistent rend of diminished mononuclear cell 
function with disease progression is observed after 
challenge with SE B, C1, D, and E, strongly sug- 
gesting biologic significance. The decrease in cellular 
proliferation is first observed in patients with 
ISCVS/SVS class 2 CVI and continues to decrease 
with disease progression. However, responses to 
PHA indicate that patients with class 2 CVI did not 
have the same degree of proliferative function com- 
pared with groups 1 and 3. This observation may 
represent a limited suppressive state before the onset 
of disease progression or to a unique interaction of 
PHA with lymphocytes and monocytes of patients 
with CVI. To determine whether this observation 
represents a suppressive state, future experiments 
should include tetanus and Candida organisms as 
additional internal controls. Tetanus and Candida 
organisms are antigens rather than mitogens. Dis- 
similar responses to these stimulants imply an effect 
unique to PHA rather than a more generalized 
suppressive state. However, the fact that cells respond 
to PHA with a positive proliferation index in our 
study demonstrates that the ceils are not globally 
unresponsive or anergic. 
Patients with LDS and a history of healed venous 
stasis ulcers exhibited the greatest decrease in func- 
tion. We speculate that the above phenomenon is 
caused by frequent episodes of epidermal breakdown, 
which has a cumulative inhibitory effect on leukocyte 
function. Exposure of circulating lymphocytes and 
monocytes to environmental toxins may cause the 
production of cytokines that are inhibitory to epi- 
dermal regeneration as discussed above. Alterna- 
tively, repeated loss of epidermal integrity may cause 
the destruction of lymphocyte and monocyte popu- 
lations responsible for wound healing. This may 
explain why patients with LDS and a history of 
healed venous tasis ulcers consistently exhibited the 
greatest decrease in function. 
The effects of the ECM and loss of epidermal 
integrity on leukocyte function are unknown. Our 
data imply that loss of epidermal integrity is associ- 
ated with diminished mononuclear p oliferative re- 
sponses. The ability to proliferate after various 
mitogenic challenges appears to decrease as the 
number of venous ulcer episodes increases and is 
poorest with the development of LDS. 
Proliferation is needed for cytokine production. 
Cytokines regulate epidermal regeneration, ECM 
production, and tissue repair. It is therefore reason- 
able to expect that alterations in the ability of 
mononuclear cells to respond to various challenges 
may manifest itself as prolonged or poor wound 
healing. The effects that ECM proteins and other 
constituents ofactive venous ulcers have on leukocyte 
function eeds further investigation. If the temporal 
relationships between leukocyte activation, cytokine 
elaboration, and keratinocyte r sponse can be deter- 
mined, restoration of epidermal integrity may be 
hastened. 
We thank Pranella Rameshwar, PhD, for her guidance 
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Feuerman, UMDNJ-New Jersey Medical School statisti- 
cian, for his help in analyzing the data. 
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